Fragile X Syndrome (FXS) is the most common form of inherited mental retardation in men. It is caused by abnormalities in the FMR1 gene that are associated with CGG repeat expansion and the hypermethylation status of its promoter. Methylated alleles lead to transcriptional inhibition and consequent loss of Fragile X Mental Retardation Protein. Chemical modification of cytosine to uracil by bisulfite treatment has proved to be an attractive method for DNA methylation studies that precludes labor-intensive Southern blot analysis, which is the gold standard test for FXS. In this report, bisulfite-treated DNA samples were amplified using real-time multiplex methylation-specific polymerase chain reaction followed by melting curve analysis. Our results show that all control samples with known CGG repeat numbers and methylation statuses were correctly diagnosed. The samples from 43 male patients were also successfully diagnosed, which were in complete agreement with the results of Southern blotting. By such means, 39 patients were found to have an unmethylated allele; 3, a fully mutated allele; and 1, both methylated and unmethylated alleles, thus implying a diagnosis of mosaicism. In conclusion, we find our method to be convenient for screening a large number of male patients with FXS, because it is rapid and easy to perform, especially when there is a low quantity of DNA that must be sensitively and accurately assayed.
Introduction
F ragile X Syndrome (FXS) is caused by an aberration of a single gene FMR1 [MIM 3009550] , which is located on the X chromosome (Xq27.3). In most cases, FXS occurs due to elongation of a polymorphic CGG triplet repeat located in the 5 0 -untranslated region of FMR1 (Bell et al., 1991; Fu et al., 1991; Kremer et al., 1991; Oberlé et al., 1991) . In normal individuals, the CGG repeats in the promoter contain between 5 and 53 copies. In the Fragile X premutation condition, the repeat number is from 60 to 200 and becomes progressively more unstable as the number of repeats increases (Sherman et al., 2005) . When the repeats number 200 or more, the elongated repeat sequence and flanking CpG island are usually hypermethylated. This phenomenon causes transcriptional silencing of the gene, which is commonly referred to as the FMR1 full mutation (Reiss et al., 1995) . A combination of several methods, such as conventional polymerase chain reaction (PCR) and Southern blot analysis, are used worldwide as gold standards for FXS diagnosis.
However, since Southern blot analysis is expensive, laborious, and time consuming in that it involves genomic DNA digestion using restriction enzymes, 18 h of electrophoresis, 18 h of DNA transfer to a membrane, 17 h of hybridization, and 2-4 h of detection on an X-ray film, alternative methods were explored for an easier but equally reliable FXS diagnosis. One such method is methylation-specific PCR (MSPCR), which was proposed by Weinhä usel and Haas in 2001 as an alternative technique for detecting FXS.
DNA methylation is a major epigenetic modification of human genomic DNA that occurs mostly at the carbon-5 position of cytosine residues within CpG islands (GardinerGarden and Frommer, 1987; Laird, 2010) . These islands are usually located in promoter regions of genes and tend to be unmethylated. Peculiar DNA methylation status is a feature of some cancers and diseases, including FXS. For MSPCR, the advantage of chemical modification of cytosine to uracil by bisulfite treatment was employed. In this reaction, all cytosines are converted to uracil, but those that are methylated (5-methylcytosine) are resistant to this modification and remain as cytosine. This altered DNA can then be amplified and sequenced, providing detailed information on the methylation status of all CpG sites within the amplified region (Frommer et al., 1992; Laird, 2010) .
Here, we explore a new alternative method for FXS diagnosis, taking advantage of the differing melting temperatures (T m ) of dissimilar PCR products. Since every PCR product melts at a characteristic temperature, different PCR products can be distinguished, and, thus, multiplexing of real-time PCR by T m analysis is made possible. This analysis is a powerful tool with a multiplexing potential parallel to that of fluorescence emission spectra (Wittwer et al., 2001) . For initial studies, multiplex MSPCR was used, because it further shortens the time and reduces the quantity of reagents needed. However, the low intensity of gel electrophoresis was still a major setback for interpreting results. Therefore, we developed a new method called multiplex methylation-specific real-time PCR (MMS-RTPCR). This method combines methylation analysis with methylation percentages of mosaic patients in a time-and cost-efficient approach.
Materials and Methods

Patients and controls
This study had been approved by the Research and Ethics Committee, School of Medical Science, USM Health Campus, Malaysia. Peripheral blood samples from a total of 43 male patients suspected to have FXS were collected in EDTA tubes. Genomic DNA was extracted from whole blood using the GENTRA PUREGENE Blood Kit (Qiagen). In addition, DNA samples with known (CGG) n repeats were obtained from the University of Amsterdam. Control samples were obtained from men with CGG repeats containing 30, 45, 60, >200, >300, and >500 copies.
Bisulfite treatment
Samples were treated with sodium bisulfite before the amplification procedure. Bisulfite treatment followed the protocol from Charalsawadi et al. (2005) , with some modifications. For the treatment, 2 mg of DNA in a volume of 50 mL was completely denatured by adding 5.5 mL of 3 M NaOH and heating at 988C for 5 min. Cold shock was then immediately performed by transferring the mixture into an ice bucket. The denatured DNA was subsequently incubated with 30 mL of 10 mM hydroquinone and 520 mL of 3 M sodium bisulfite solution at 558C for 5 h. Purification steps were done using the GENE ALLÔ Blood SV mini kit (Gene All). Modified DNA was desulphonated by adding 34 mL of 10 mM ammonium acetate and 340 mL of cold absolute ethanol. Desulphonated DNA was then precipitated in 70% ethanol. Finally, the modified DNA was dissolved in 20 mL of elution buffer and stored at À208C.
Multiplex methylation-specific real-time PCR
Methylation analysis of FMR1 was simplified by a newly developed method termed MMS-RTPCR. This newly developed method improves on the method outlined by Weinhausel and Haas (2001); we have used real-time PCR in place of conventional MSPCR. For this method, identification of methylation status was determined by a melting curve analysis (MCA), which provides quantitative results.
The mixture for multiplex methylation-specific amplification of FMR1 was prepared in a total volume of 20 mL, with three replicates for each sample. Each reaction mixture consisted of 1 mL bisulfite-treated DNA, 1Âfinal buffer concentration, 2.5 mM MgCl 2 , 0.35 mM each of primers PUF ( (2001); they target sequences *400 bp downstream from the CpG island in the FMR1 promoter. Multiplexing the amplification allowed differentiation between methylated and unmethylated strands to be more easily achieved after bisulfite treatment of the genomic DNA.
For the LightCycler Ò real-time PCR System, Lightcycler capillaries were used instead of the microcentrifuge tubes used in conventional PCR. Capillaries were placed in a precooled centrifuge adaptor, and preparation of the PCR mixture was carried out in the same adaptor box for optimum temperature and to prevent the fluorescent dye from being exposed to direct light. Then, bisulfite-treated DNA was loaded into the capillaries followed by 19 mL of the master mix, and a quick centrifugation was performed. The capillaries were then transferred into the LightCycler sample carousel. The bisulfite-treated DNA was amplified by applying 10 min of hot start at 958C, followed by 37 cycles of denaturation at 958C for 15 s, annealing at 618C for 10 s, and elongation at 728C for 45 s. Subsequently, a melting curve program was applied with a temperature increment from 608C to 958C at 0.058C/s. The fluorescence reading was continuously taken by the machine at each temperature increment. Finally, the capillaries were cooled to 408C. After all programs were finished, melting peak graphs [fluorescence-d(F1)/dT vs. temperature] were generated from the LightCycler Software 4.05. The methylation status of each sample was then identified by analyzing the melting peaks created. Artificial mosaic samples were generated and used to create melting peak standard curves for quantification of methylation percentages in mosaic samples.
For validation of results, all untreated genomic DNA was amplified, and CGG repeats were identified using conventional PCR. Samples with methylated and mosaic patterns of methylation status were subjected to Southern blot analysis using double digestion by EcoRI and EagI restriction enzymes followed by detection using the StB12.3 probe.
In the present study, the cost and time duration for both methods were compared to evaluate cost effectiveness and time efficiency for MMS-RTPCR over Southern blot analysis.
Results
We have successfully developed a new method for FXS screening using MMS-RTPCR with MCA. In this analysis, temperatures of the melting peaks for each samples were explored. During the optimization phase, amplifications of methylation-specific real-time PCR (MS-RTPCR) were done 388 ELIAS ET AL.
separately for each set of primers. The sample used for each optimization was normal female bisulfite-treated DNA. Figure 1 shows the MCA of method optimization using four sets of primers separately. From the melting peaks generated, both unmethylated (XU) and methylated (XM) portions of XIST gene promoter have nearly the same melting peak temperature (788C). On the other hand, the melting peak temperatures for the unmethylated FMR1 gene promoter (PU) and the methylated FMR1 gene promoter (PM) were 84.58C and 90.58C, respectively. However, since the melting peaks of XU and XM cannot be differentiated from the melting peak of primer dimers, XIST gene amplifications were eliminated from the method.
After full optimization, multiplex amplification of MS-RTPCR was developed. Both PU and PM primers were combined in a single amplification. After amplification, a melting curve was analyzed to generate a melting peak from each sample. From the melting peaks generated (Fig. 2) , normal female samples were identified as having two melting peaks at *858C and 918C, which are identical to the PU and PM melting peak temperatures, respectively. A normal man was identified as possessing a melting curve identical to PU, with a temperature of 858C. A control sample that was known to be methylated and comprised 500 CGG repeats was found to produce a melting curve identical to the PM melting peaks at 918C. MMS-RTPCR analysis was then applied to other control samples with known methylation statuses and CGG repeats. Interestingly, the methylation status of all control samples was correctly determined. By using this system, fully methylated control samples with CGG repeats of 500, 300, and 200 (CGG) n copies were correctly determined as having a
FIG. 2.
Melting curve analysis of multiplex methylation-specific real-time polymerase chain reaction using real-time polymerase chain reaction for a normal male control (NM), a normal female control (NF), and a fully mutated control with >500 CGG repeats.
FIG. 1.
Melting curve analysis of a normal woman using methylation-specific real-time polymerase chain reaction for the four pairs of primers separately.
FMR1 GENE METHYLATION SCREENING USING MMS-RTPCR
methylated FMR1 promoter. The T m of the methylated FMR1 promoter for all triplicate control samples varied slightly within a small range (90.888C AE 0.118C). As predicted, the control samples of premutation women (P1 and P2) were found to have both methylated and unmethylated promoters.
The T m for both methylated and unmethylated FMR1 promoters were found to be scattered within a small range. This result leads to a variation in the temperature between 83.638C and 85.948C (84.898C AE 0.428C) for the unmethylated FMR1 promoter. For the methylated FMR1 promoter, the temperature of melting peaks ranged between 90.27 and 90.92 (90.578C AE 0.348C). This exceptionally small range variation for melting peak temperatures is shown in Figure 3 .
After successful verification of this system using the control samples, the method was then applied to patient samples (Fig.  3) . From a total of 43 male samples, 7% (n ¼ 3) were found to be fully mutated. In one sample (2.3%), the methylation status was mosaic, because both methylated and unmethylated FMR1 promoters were observable from the MCA. All samples were also tested by conventional PCR and Southern blot analysis. As expected, the validation tests using PCR and Southern blotting supported the results of real-time Multiplex MSPCR analysis, with total agreement of results for all patients, thus suggesting the reliability of our newly developed method.
The methylation percentage for the patient with mosaicism was calculated based on the standard curve of the melting peak generated from the fluorescence intensity of methylated and unmethylated control sample mixtures at differing ratios. One patient with a mosaic allele pattern was identified to have *30% methylation. From the evaluation test, we found that the lowest percentage of methylation that can be detected in our synthetic mosaic sample using our method was *5% (Fig. 4) .
Further, an evaluation of time efficiency for both methods (Table 1) showed that MMS-RTPCR is approximately thrice more rapid than the Southern blot method. An evaluation of cost effectiveness showed that MMS-RTPCR is 84.6% less expensive than the Southern blot method. When compared with the MS-PCR technique reported by Weinhä usel and Haas (2001), MMS-RTPCR is more sensitive, avoids gel electrophoresis and its accompanying biohazards (e.g., ethidium bromide), and may be superior when dealing with large sample numbers (i.e., for FXS screening of a population).
Discussion
The demand for cheaper, faster, and more sensitive laboratory methods for diagnosis of FXS has tremendously increased. The standard available method for FXS diagnosis is still lengthy and laborious, as the diagnosis combines conventional PCR and Southern blot analysis. Therefore, we explored a new method for FXS diagnosis using real-time PCR.
In the multiplex amplification that we performed using real-time PCR with SYBR green chemistry, the C T values obtained were not suitable for analysis, because more than one PCR product was amplified and detected by SYBR green. However, melting peak analysis generated from multiplexing real-time PCR and T m is a powerful tool to distinguish different sequences. According to Wittwer et al. (2001) , melting curves generated from continuous monitoring during temperature elevation are ''dynamic dot blots.'' Thus, different duplexes can be detected with confidence, as they melt at different temperatures.
After melting profiles of the samples are obtained, there is no need for gel electrophoresis, thus making our technique a closed-tube method that thereby reduces the risk of contamination. Our results demonstrate that MMS-RTPCR has better resolution when compared with gel electrophoresis, because quantitative analysis of the fluorescence intensity can be measured and compared between primer pairs by melting peak analysis. Further, due to the higher resolution, our method can identify the methylation status even for samples of low amounts, up to 80% lower than that needed for conventional MSPCR. This was proved by the ability of our method to detect treated genomic DNA at as low as 0.05 ng/ mL and confirmed by titration experiments (data not shown).
FIG. 3.
Melting curve analysis for patient's samples with small melting peak temperature variation. Two samples were found to be problematic with un-amplified PU and PM region. A patient was identified as fully mutated with only PM peak and another patient was mosaic with PM (*) and PU (**) melting peaks.
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Nevertheless, with the use of our close-tube method, we find that the risk of contamination is very low. One limitation of this method is an inability to identify the methylation status for women, that is, premutated and fully mutated DNA from women cannot be differentiated from that of normal women. This is due to random X inactivation that occurs naturally for X chromosomes of all women. However, since men are more commonly affected with FXS in the general population, this limitation is not a major problem for FXS screening.
In 2007 
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method, because both use MCA for methylation status differentiation. However, Dahl et al. (2007) used a single primer pair that amplifies both methylated and unmethylated alleles. In contrast, we have performed multiplex amplification with two pairs of primers that are specific for methylated and unmethylated alleles. This produced greater T m differences between the methylated and unmethylated alleles. The higher T m of both methylated and unmethylated alleles also help distinguish their melting peaks from the primer dimer peak.
Although MMS-RTPCR is a very sensitive method for determining methylation status, it is incapable of identifying the number of CGG repeats, because our primers are not designed to amplify the CGG repeat region. Wang et al. (1996) reported a case of a fully expanded allele with minimal methylation in a high-functioning fragile X man with normal IQ. This report and several other reports (McConkie-Rosell et al., 1993; Hagerman et al., 1994; Merenstein et al., 1994) show that, in addition to CGG repeat number, the level of methylation plays a role in predicting a patient's FMRP expression level, as do the clinical characteristics.
Conclusion
Our results show that MMS-RTPCR is a reliable and more sensitive method as compared with conventional MSPCR. It is very convenient for screening a large number of male patients with FXS, because it is less time consuming and easier to perform, with an uncomplicated analysis. Moreover, this test is a method of choice when low quantities of DNA need to be sensitively and accurately determined. 
